Results 171 to 180 of about 398,598 (315)
Back Again to the Future: A New Era for Cerebroprotection
Cerebroprotection is a fresh framework for designing neurological therapy that targets glia and vascular cells, in addition to neurons. In the future, successful cerebroprotection will involve targeting all elements of the neurovascular unit. Preclinical trials must include functional outcomes, as well as lesion morphometry.
Patrick Lyden
wiley +1 more source
The Programmed Placebo Effect in Patients with Syncope: Preliminary Clinical and Nanostructural Insights with a Hypothetical Quantum-Level Interpretation. [PDF]
Hadžić B +5 more
europepmc +1 more source
Compression-induced improvements in post-exercise recovery are associated with enhanced blood flow, and are not due to the placebo effect. [PDF]
O'Riordan SF +3 more
europepmc +1 more source
Objective Biomarkers with clear contexts of use are important tools for amyotrophic lateral sclerosis (ALS) therapy development. Understanding their longitudinal trajectory in the untreated state is key to their use as potential markers of pharmacodynamic response.
Oleksandr Dergai +16 more
wiley +1 more source
Myths and Truths about Placebo Effect in Rehabilitation for Musculoskeletal Pain. [PDF]
Iolascon G, Moretti A.
europepmc +1 more source
Implantable Drug Delivery Systems for Skeletal Muscles and Eyes
This review highlights the different types of recent implantable drug delivery systems (IDDS) fabricated for a use with skeletal muscles, and with eyes. It presents the developments already made and the current research directions, showing the evolution of IDDS and their great diversity.
Serge Ostrovidov +8 more
wiley +1 more source
Justice for Placebo: Placebo Effect in Clinical Trials and Everyday Practice. [PDF]
Knezevic NN +3 more
europepmc +1 more source

